NCT06717529View on ClinicalTrials.gov

Functional and Clinical Outcomes of Hyaluronic Acid and Steroid Injections in Bilateral Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

November 15, 2023

Study Completion Date

September 30, 2024

Conditions
Osteoarthritis (OA) of the KneeOsteoarthritisOsteoarthritis in the KneeOsteoarthritis of KneeOsteoarthritis of the KneesOsteoarthritis of Knee JointOsteoarthritis KneeOsteoarthritis of the Knee
Interventions
OTHER

Sodium hyaluronate (hyaluronic acid)

The patient will receive one 3mL Sodium Hyaluronate injection containing 75 mg of active substance in one knee joint.

DRUG

Methylprednisolone Acetate Injection

The patient will receive 2mL of methylprednisolone acetate solution containing 80 mg of the medicine in other knee joint.

Trial Locations (1)

88000

"Cantonal Hospital dr.Safet Mujic", Mostar

All Listed Sponsors
lead

Edin Mešanović

OTHER